Works matching IS 02704137 AND DT 2009 AND VI 69 AND IP 6

Results: 10

Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.

Published in:

Prostate, 2009, v. 69, n. 6, p. 603, doi. 10.1002/pros.20910

By:

Hansel, Donna E.;
Nakayama, Masashi;
Luo, Jun;
Abukhdeir, Abde M.;
Park, Ben H.;
Bieberich, Charles J.;
Hicks, Jessica L.;
Eisenberger, Mario;
Nelson, William G.;
Mostwin, Jasek L.;
De Marzo, Angelo M.

Publication type:

Article

An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: A HuGE Review.

Published in:

Prostate, 2009, v. 69, n. 6, p. 662, doi. 10.1002/pros.20907

By:

Mo, Zengnan;
Gao, Yong;
Cao, Yunfei;
Gao, Feng;
Jian, Lijuan

Publication type:

Article

Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.

Published in:

Prostate, 2009, v. 69, n. 6, p. 652, doi. 10.1002/pros.20913

By:

Wakchoure, Savita;
Swain, Telisha Millender;
Hentunen, Teuvo A.;
Bauskin, Asne R.;
Brown, David A.;
Breit, Samuel N.;
Vuopala, Katri S.;
Harris, Kevin W.;
Selander, Katri S.

Publication type:

Article

Piperazine-designed α<sub>1A</sub>/α<sub>1D</sub>-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.

Published in:

Prostate, 2009, v. 69, n. 6, p. 610, doi. 10.1002/pros.20919

By:

Liu, Chi-Ming;
Lo, Yi-Ching;
Tai, Ming-Hong;
Wu, Bin-Nan;
Wu, Wen-Jeng;
Chou, Yii-Her;
Chai, Chee-Yin;
Huang, Chun-Hsiung;
Chen, Ing-Jun

Publication type:

Article

Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization.

Published in:

Prostate, 2009, v. 69, n. 6, p. 571, doi. 10.1002/pros.20906

By:

Koh, Yi T.;
Gray, Andrew;
Higgins, Sean A.;
Hubby, Bolyn;
Kast, W. Martin

Publication type:

Article

Il-1β-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation.

Published in:

Prostate, 2009, v. 69, n. 6, p. 633, doi. 10.1002/pros.20916

By:

Vykhovanets, Eugene V.;
Shukla, Sanjeev;
MacLennan, Gregory T.;
Vykhovanets, Olena V.;
Bodner, Donald R.;
Gupta, Sanjay

Publication type:

Article

In vitro targeted photodynamic therapy with a pyropheophorbide-a conjugated inhibitor of prostate-specific membrane antigen.

Published in:

Prostate, 2009, v. 69, n. 6, p. 585, doi. 10.1002/pros.20909

By:

Liu, Tiancheng;
Wu, Lisa Y.;
Choi, Joseph K.;
Berkman, Clifford E.

Publication type:

Article

Suppression of prostate cancer in a transgenic rat model via γ-tocopherol activation of caspase signaling.

Published in:

Prostate, 2009, v. 69, n. 6, p. 644, doi. 10.1002/pros.20915

By:

Takahashi, Satoru;
Takeshita, Kentaro;
Seeni, Azman;
Sugiura, Satoshi;
Tang, Mingxi;
Sato, Shin-ya;
Kuriyama, Hiroki;
Nakadate, Masao;
Abe, Koichi;
Maeno, Yoshitaka;
Nagao, Masataka;
Shirai, Tomoyuki

Publication type:

Article

Overexpression of 5α-reductase type 1 increases sensitivity of prostate cancer cells to low concentrations of testosterone.

Published in:

Prostate, 2009, v. 69, n. 6, p. 595, doi. 10.1002/pros.20911

By:

Thomas, Lynn N.;
Douglas, Robert C.;
Rittmaster, Roger S.;
Too, Catherine K.L.

Publication type:

Article

Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid.

Published in:

Prostate, 2009, v. 69, n. 6, p. 624, doi. 10.1002/pros.20917

By:

Lein, Michael;
Miller, Kurt;
Wirth, Manfred;
Weißbach, Lothar;
May, Christoph;
Schmidt, Katja;
Haus, Ulrike;
Schrader, Mark;
Jung, Klaus

Publication type:

Article